These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8962121)
21. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Stranford SA; Skurnick J; Louria D; Osmond D; Chang SY; Sninsky J; Ferrari G; Weinhold K; Lindquist C; Levy JA Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1030-5. PubMed ID: 9927688 [TBL] [Abstract][Full Text] [Related]
22. HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice. Dudek TE; Allen TM J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S150-4. PubMed ID: 24151322 [TBL] [Abstract][Full Text] [Related]
23. Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals. Addo MM; Altfeld M; Brainard DM; Rathod A; Piechocka-Trocha A; Fideli U; Mulenga J; Shutes E; Alvino DM; Hunter E; Allen SA; Walker BD J Infect Dis; 2011 Jan; 203(2):258-62. PubMed ID: 21288826 [TBL] [Abstract][Full Text] [Related]
24. Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals. Tsuchie H; Detorio MA; Hossain MM; Tesfamariam N; Trickett A; Lam-Po-Tang PR; Yamada O; Ichimura H; Dwyer JM; Kurimura T Int J STD AIDS; 1997 May; 8(5):307-10. PubMed ID: 9175652 [TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of BALb/c mouse splenocytes reduces lesion severity and induces intestinal pathophysiologic changes in the Mycobacterium avium Subspecies paratuberculosis beige/scid mouse model. Mutwiri GK; Rosendal S; Kosecka U; Yager JA; Perdue M; Snider D; Butler DG Comp Med; 2002 Aug; 52(4):332-41. PubMed ID: 12211277 [TBL] [Abstract][Full Text] [Related]
26. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891 [TBL] [Abstract][Full Text] [Related]
27. Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. Clark DR; Ampel NM; Hallett CA; Yedavalli VR; Ahmad N; DeLuca D J Infect Dis; 1997 Sep; 176(3):649-54. PubMed ID: 9291311 [TBL] [Abstract][Full Text] [Related]
28. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice. Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108 [TBL] [Abstract][Full Text] [Related]
30. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells. Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084 [TBL] [Abstract][Full Text] [Related]
31. The role of cytotoxic T-cells in HIV infection. Rowland-Jones S; Dong T; Krausa P; Sutton J; Newell H; Ariyoshi K; Gotch F; Sabally S; Corrah T; Kimani J; MacDonald K; Plummer F; Ndinya-Achola J; Whittle H; McMichael A Dev Biol Stand; 1998; 92():209-14. PubMed ID: 9554277 [TBL] [Abstract][Full Text] [Related]
32. Role of CD4+, CD8+ and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi. Ross TL; Balson GA; Miners JS; Smith GD; Shewen PE; Prescott JF; Yager JA Can J Vet Res; 1996 Jul; 60(3):186-92. PubMed ID: 8809381 [TBL] [Abstract][Full Text] [Related]
33. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680 [TBL] [Abstract][Full Text] [Related]
34. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles. Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762 [TBL] [Abstract][Full Text] [Related]
36. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells. Wang L; Wen W; Yuan J; Helfand B; Li Y; Shi C; Tian F; Zheng J; Wang F; Chen L; Liang L; Zhou L; Lee C; Chen Z; Guo Y; Wang H; Zhang Q; Qin W Clin Cancer Res; 2010 Jan; 16(1):164-73. PubMed ID: 20028741 [TBL] [Abstract][Full Text] [Related]
37. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes. Baiocchi RA; Caligiuri MA Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the significance of CD4+ and CD8+ T lymphocytes in the protection of mice against Encephalitozoon cuniculi infection. Braunfuchsová P; Salát J; Kopecký J J Parasitol; 2002 Aug; 88(4):797-9. PubMed ID: 12197135 [TBL] [Abstract][Full Text] [Related]
39. HIV infection accelerates gastrointestinal tumor outgrowth in NSG-HuPBL mice. Lu R; Wu S; Zhang Y; Xia Y; Huelsmann EJ; Lacek AT; Nabatiyan A; Richards MH; Narasipura SD; Lutgen V; Chen H; Kaufman HL; Chen D; Al-Harthi L; Zloza A; Sun J AIDS Res Hum Retroviruses; 2014 Jul; 30(7):677-84. PubMed ID: 24593860 [TBL] [Abstract][Full Text] [Related]
40. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Alimonti JB; Kimani J; Matu L; Wachihi C; Kaul R; Plummer FA; Fowke KR Immunol Cell Biol; 2006 Oct; 84(5):482-5. PubMed ID: 16942489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]